Defective DNA Damage Response is a Targetable Therapeutic Vulnerability in ESR1 Mutant Breast Cancer.
已完结20由 达姆 发布于 2026/1/15 15:47:31
DOI:10.1158/0008-5472.can-24-3891
作者:Sarah K Herzog,Jessica H Stevens,Guowei Gu,Sandra L Grimm,Kloma Cardoza,Autumn G M Hawkins,Hangqing Lin,Daniela Ramos,Amanda R Beyer,David G Edwards,Derek Dustin,Harry J Yang,Nicole Liang,Ashfia F Kha
文献类型:期刊论文
补充材料:只需要正文